Business Context and Reporting Period
This Form 6-K filing by Diginex Ltd covers the month of January 2026, with the report dated January 14, 2026. The filing primarily announces the closing of the acquisition of The Remedy Project Limited, a Hong Kong-based ESG advisory company, on January 8, 2026.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial statements (revenue, profit, cash flow, or margins) for the reporting period. However, it details the financial structure of the acquisition:
- Initial Consideration: 1,000,000 Diginex ordinary shares issued to the seller, valued at $3,790,000 ($3.79 per share).
- Earn-Out Potential: Up to an additional 1,000,000 Diginex ordinary shares contingent on meeting operating targets over three years.
- Debt and Liquidity: The filing text does not provide clear values for the company's current debt levels or liquidity position.
Material Changes and Transaction Structure
The primary material change is the 100% acquisition of The Remedy Project. The transaction structure includes:
- Employment: Archana Kotecha, founder and CEO of The Remedy Project, has been hired as Diginex's Head of Advisory.
- Earn-Out Tranches:
- First Tranche (250,000 shares): Issuable on March 27, 2026, subject to continued employment.
- Second Tranche (250,000 shares): Issuable 18 months after closing, subject to continued employment.
- Third Tranche (250,000 shares): Contingent on achieving adjusted EBITDA of $4.1 million for the year ending March 31, 2028.
- Fourth Tranche (250,000 shares): Contingent on achieving adjusted EBITDA of $8.2 million for the year ending March 31, 2029.
Outlook, Management Commentary, and Risks
Management views the acquisition as a strategic move to combine Diginex's AI-powered supply chain technology (diginexLUMEN and diginexAPPRISE) with The Remedy Project's expertise in human rights due diligence and grievance mechanisms. The goal is to create a comprehensive ecosystem for ethical operations and compliance with regulations like the EU Corporate Sustainability Due Diligence Directive.
Risks and Contingencies:
- Employment Risk: The issuance of the first two earn-out tranches is dependent on the seller not terminating her employment in violation of her agreement.
- Performance Risk: The final two tranches are contingent on meeting specific adjusted EBITDA targets in 2028 and 2029.
Key Facts for Investor Verification
- Verify the current share price of Diginex to assess the real-time value of the $3.79 per share valuation used in the transaction.
- Confirm the specific definition of "adjusted EBITDA" in the Share Purchase Agreement (SPA) to evaluate the feasibility of the $4.1 million and $8.2 million targets.
- Review the employment agreement terms for Archana Kotecha to understand the conditions under which the first two earn-out tranches could be forfeited.
- Check subsequent filings for the impact of this acquisition on Diginex's consolidated financial statements and dilution effects.